Patients coping with mesothelioma experienced higher levels of toxicity on CheckMate743 regimen than reported in trials

Based on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of care for the treatment of unresectable pleural mesothelioma. However, research published today in the Journal of Thoracic Oncology (JTO) showed that a group of Australian patients treated with that immunotherapy combination experienced higher levels of toxicity than were reported in the clinical trial results.

School-based mental health services can improve the well-being of children and adolescents

Mental health in young people across the U.S. is suffering: rates of anxiety, depression and other mental health challenges remain high, and suicide is the second-leading cause of death. To address these challenges, school-based mental health (SBMH) services are being offered by some school districts as a way to identify and treat children and adolescents who may not have access to other mental health services.

Reducing inequitable health outcomes requires reducing residential segregation, says study

The U.S. must reduce racial residential segregation if it is to reduce racial disparities in health outcomes, according to a recently published study by researchers at Tufts University School of Medicine. The research on 220 metropolitan areas nationwide between 1980 and 2020 found strong links between trends in racial residential segregation and racial disparities in early death rates from a variety of causes.

Millions of kids in US have inadequate health care coverage

Inadequate health coverage is a particular problem for commercially insured children, according to a new study released by Columbia University Mailman School of Public Health. The research shows that coverage gaps are affecting publicly insured children as well. Until now, prior research had focused on documenting rates and trends in insurance consistency for children covered by all insurance types. The findings are published in JAMA Health Forum.